Adam Boehler officially named new CMMI director

In an email to CMS staff, agency administrator Seema Verma announced Adam Boehler, CEO of home-based care startup Landmark Health, has been named the new head of the Center for Medicaid and Medicare Innovation (CMMI).

Boehler’s selection has been rumored for months. He doesn’t bring any government experience, with his resume mostly centered on venture capital and startups. Before founding Landmark Health, he was running another healthcare startup, lab management company Accumen. Other past roles include executive vice president and general manager at analytics provider MedeFinance and a principal healthcare investor at Accretive.

“Adam is widely regarded as an innovative leader in the private sector and in him we are lucky to have someone who has designed and implemented new, patient-focused approaches to healthcare delivery,” Verma wrote to CMS staff.

How exactly Trump administration officials will utilize CMMI remains an open question. Created under the Obama administration, the center was the driving force behind sometimes-controversial experiments with Medicaid and Medicare payment models. Some of those plans were rolled back under Verma and former HHS Secretary Tom Price, like their cancellation of several mandatory bundled payment models for cardiac and orthopedic care.

Since then, CMS has collected comments on a “new direction” for CMMI, with the promise the center would focus on mandatory models in the future. The second HHS Secretary under President Donald Trump, Alex Azar, has a different opinion on mandatory payment experiments, saying in one of his confirmation hearings he would support them if it was necessary to “get adequate data.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.